Iva Petkovska

Iva Petkovska

Auto-generated profile, based on publicly available information

Iva Petkovska

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in JAMA Oncology
Verified
Journal Article
Closed access
PDF file
JSJ. Joshua Smith
J. Joshua Smith
PSPaul Strombom
Paul Strombom
OCOliver S. Chow
Oliver S. Chow
CRCampbell S. Roxburgh
Campbell S. Roxburgh
PLPatricio Lynn
Patricio Lynn
PPPhilip B. Paty
Philip B. Paty
Importance The watch-and-wait (WW) strategy aims to spare patients with rectal cancer unnecessary resection. Objective To analyze the outcomes of WW among patients with rectal cancer who had a clinical complete response to neoadjuvant therapy. Design, Setting, and Participants This retrospective case series analysis conducted at a comprehensive cancer center in New York included patients who received a diagnosis of rectal adenocarcinoma between January 1, 2006, and January 31, 2015. The median follow-up was 43 months. Data analyses were conducted from June 1, 2016, to October 1, 2018. Exposures Patients had a clinical complete response after completing neoadjuvant therapy and agreed to a WW strategy of active surveillance and possible salvage surgery (n = 113), or patients underwent total mesorectal excision and were found to have a pathologic complete response (pCR) at resection (n = 136). Main Outcomes and Measures Kaplan-Meier estimates were used for analyses of local regrowth and 5-year rates of overall survival, disease-free survival, and disease-specific survival. Results Compared with the 136 patients in the pCR group, the 113 patients in the WW group were older (median [range], 67.2 [32.1-90.9] vs 57.3 [25.0-87.9] years,P < .001) with cancers closer to the anal verge (median [range] height from anal verge, 5.5 [0.0-15.0] vs 7.0 [0.0-13.0] cm). All 22 local regrowths in the WW group were detected on routine surveillance and treated by salvage surgery (20 total mesorectal excisions plus 2 transanal excisions). Pelvic control after salvage surgery was maintained in 20 of 22 patients (91%). No pelvic recurrences occurred in the pCR group. Rectal preservation was achieved in 93 of 113 patients (82%) in the WW group (91 patients with no local regrowths plus 2 patients with local regrowths salvaged with transanal excision). At 5 years, overall survival was 73% (95% CI, 60%-89%) in the WW group and 94% (95% CI, 90%-99%) in the pCR group; disease-free survival was 75% (95% CI, 62%-90%) in the WW group and 92% (95% CI, 87%-98%) in the pCR group; and disease-specific survival was 90% (95% CI, 81%-99%) in the WW group and 98% (95% CI, 95%-100%) in the pCR group. A higher rate of distant metastasis was observed among patients in the WW group who had local regrowth vs those who did not have local regrowth (36% vs 1%,P < .001). Conclusions and Relevance A WW strategy for select rectal cancer patients who had a clinical complete response after neoadjuvant therapy resulted in excellent rectal preservation and pelvic tumor control; however, in the WW group, worse survival was noted along with a higher incidence of distant progression in patients with local regrowth vs those without local regrowth.

1 March 2019 in RadioGraphics
Verified
Journal Article
Closed access
Natally HorvatNatally Horvat
Natally Horvat
CRCamila Carlos Tavares Rocha
Camila Carlos Tavares Rocha
BOBrunna Clemente Oliveira
Brunna Clemente Oliveira
IPIva Petkovska
Iva Petkovska
MGMarc J. Gollub
Marc J. Gollub
In this review of rectal MRI techniques and rectal anatomy, the authors describe current concepts in rectal cancer management; demonstrate the role of rectal MRI in local staging, restaging, and recurrence; and discuss future directions in imaging research. Rectal cancer is prone to local recurrence and systemic metastasis. However, owing to improvements in TNM staging and treatment, including a more widespread use of rectal MRI and increased radiologist awareness of the key rectal cancer TNM staging features, the mortality rate of rectal cancer has been declining over the past few decades in adults over 50 years of age. Currently, rectal MRI plays a key role in the pre- and posttreatment evaluation of rectal cancer, assisting the multidisciplinary team in tailoring the most appropriate treatment option. The benefits achieved with rectal MRI are strictly dependent on obtaining good-quality images, which is important for the characterization of the main anatomic structures and their relationship with the tumor. In primary staging, rectal MRI helps the radiologist (a) describe the tumor location and morphology, (b) provide its T and N categories, (c) detect the presence of extramural vascular invasion, and (d) identify its relationship with surrounding structu...

1 June 2018 in Radiology
Verified
Journal Article
Closed access
Natally HorvatNatally Horvat
Natally Horvat
HVHarini Veeraraghavan
Harini Veeraraghavan
MKMonika Khan
Monika Khan
IBIvana Blazic
Ivana Blazic
JZJunting Zheng
Junting Zheng
IPIva Petkovska
Iva Petkovska
The radiomics measures by using cross-validation showed better classification performance compared with the qualitative assessment for diagnosing pathologic complete response in patients with locally advanced rectal cancer after neoadjuvant therapy. Purpose To investigate the value of T2-weighted–based radiomics compared with qualitative assessment at T2-weighted imaging and diffusion-weighted (DW) imaging for diagnosis of clinical complete response in patients with rectal cancer after neoadjuvant chemotherapy–radiation therapy (CRT). Materials and Methods This retrospective study included 114 patients with rectal cancer who underwent magnetic resonance (MR) imaging after CRT between March 2012 and February 2016. Median age among women (47 of 114, 41%) was 55.9 years (interquartile range, 45.4–66.7 years) and median age among men (67 of 114, 59%) was 55 years (interquartile range, 48–67 years). Surgical histopathologic analysis was the reference standard for pathologic complete response (pCR). For qualitative assessment, two radiologists reached a consensus. For radiomics, one radiologist segmented the volume of interest on high-spatial-resolution T2-weighted images. A random forest classifier was trained to separate the patients by their outcomes af...


1 April 2023 in Radiology
Verified
Journal Article
Closed access
VJVetri Sudar Jayaprakasam
Vetri Sudar Jayaprakasam
JAJanet Alvarez
Janet Alvarez
DODana M Omer
Dana M Omer
MGMarc J. Gollub
Marc J. Gollub
JSJ. Joshua Smith
J. Joshua Smith
IPIva Petkovska
Iva Petkovska
MRI plays a critical role in assessing clinical complete response for patient selection and monitoring with the watch and wait strategy, otherwise known as nonoperative management, in rectal cancer... The diagnosis and treatment of rectal cancer have evolved dramatically over the past several decades. At the same time, its incidence has increased in younger populations. This review will inform t...

1 November 2020 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
IPIva Petkovska
Iva Petkovska
FTFlorent Tixier
Florent Tixier
EOEduardo J. Ortiz
Eduardo J. Ortiz
JPJennifer S. Golia Pernicka
Jennifer S. Golia Pernicka
VPViktoriya Paroder
Viktoriya Paroder
HVHarini Veeraraghavan
Harini Veeraraghavan